Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic

Peking University

Status: Completed

Conditions: Asthma; Pulmonary Disease, Chronic Obstructive

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04948216

LM2020133

Details and patient eligibility

About

During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the influencing factors during the COVID-19 epidemic.

Full description

During the COVID-19 epidemic, the medical treatment, disease status, and medication status of patients with chronic airway disease have not been studied. The purpose of this study is to investigate the management and healthcare utilization of patients with chronic airway disease and the relevant factors during the COVID-19 epidemic. Using cross-sectional research methods, telephone interviews and questionnaire surveys were used to investigate the management and healthcare utilization of patients with chronic airway disease （COPD and asthma）during the COVID-19 epidemic.

Enrollment: 153 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• COPD patients and asthma patients in the Chronic Airway Disease Database in Peking University Third Hospital.

Exclusion criteria

• Refusal to participate in this study; cognitive dysfunction.